Harrow, Inc. (HROW)
28.44
+0.29
(+1.03%)
USD |
NASDAQ |
Oct 23, 16:00
28.43
-0.01
(-0.04%)
After-Hours: 20:00
Harrow EPS Diluted (Quarterly) : -0.4624 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4624 |
| March 31, 2026 | -0.7414 |
| December 31, 2025 | 0.178 |
| September 30, 2025 | 0.0262 |
| June 30, 2025 | 0.1286 |
| March 31, 2025 | -0.4963 |
| December 31, 2024 | 0.1893 |
| September 30, 2024 | -0.1182 |
| June 30, 2024 | -0.1817 |
| March 31, 2024 | -0.3824 |
| December 31, 2023 | -0.2588 |
| September 30, 2023 | -0.1282 |
| June 30, 2023 | -0.1388 |
| March 31, 2023 | -0.2193 |
| December 31, 2022 | 0.0358 |
| September 30, 2022 | -0.2364 |
| June 30, 2022 | -0.2285 |
| March 31, 2022 | -0.0895 |
| December 31, 2021 | -0.2757 |
| September 30, 2021 | -0.3072 |
| June 30, 2021 | -0.1103 |
| March 31, 2021 | 0.0079 |
| December 31, 2020 | 0.0446 |
| September 30, 2020 | 0.3189 |
| June 30, 2020 | -0.0092 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.499 |
| December 31, 2019 | 0.1041 |
| September 30, 2019 | -0.4483 |
| June 30, 2019 | -0.0943 |
| March 31, 2019 | 0.4272 |
| December 31, 2018 | 0.7449 |
| September 30, 2018 | -0.1158 |
| June 30, 2018 | 0.1088 |
| March 31, 2018 | -0.1677 |
| December 31, 2017 | -0.1344 |
| September 30, 2017 | -0.28 |
| June 30, 2017 | 0.064 |
| March 31, 2017 | -0.2645 |
| December 31, 2016 | -0.44 |
| September 30, 2016 | -0.29 |
| June 30, 2016 | -0.35 |
| March 31, 2016 | -0.43 |
| December 31, 2015 | -0.53 |
| September 30, 2015 | -0.41 |
| June 30, 2015 | -0.39 |
| March 31, 2015 | -0.33 |
| December 31, 2014 | -0.30 |
| September 30, 2014 | -0.27 |
| June 30, 2014 | -0.28 |
| March 31, 2014 | -0.26 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viatris, Inc. | -0.1021 |
| 60 Degrees Pharmaceuticals, Inc. | -0.903 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.27M |
| Revenue (Quarterly) | 70.66M |
| Total Expenses (Quarterly) | 87.93M |
| Enterprise Value | 1.283B |
| Gross Profit Margin (Quarterly) | 71.27% |
| Profit Margin (Quarterly) | -24.44% |
| Earnings Yield | -3.51% |
| Operating Earnings Yield | 0.53% |
| Normalized Earnings Yield | -2.465 |